Published in J Immunol on May 15, 2009
The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep (2014) 4.97
SOCS3 deficiency promotes M1 macrophage polarization and inflammation. J Immunol (2012) 1.71
The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology (2010) 1.64
Effect of helminth-induced immunity on infections with microbial pathogens. Nat Immunol (2013) 1.55
The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS (2015) 1.53
A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron (2009) 1.48
Macrophage polarization in health and disease. ScientificWorldJournal (2011) 1.46
Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation. Retrovirology (2015) 1.43
Macrophages and their relevance in Human Immunodeficiency Virus Type I infection. Retrovirology (2012) 1.41
Recently infiltrating MAC387(+) monocytes/macrophages a third macrophage population involved in SIV and HIV encephalitic lesion formation. Am J Pathol (2011) 1.34
Antiretroviral therapy in macrophages: implication for HIV eradication. Antivir Chem Chemother (2009) 1.27
HIV-1 latency in monocytes/macrophages. Viruses (2014) 1.13
The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol (2013) 1.13
Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons. Sci Rep (2012) 1.12
Antigen-presenting cells represent targets for R5 HIV-1 infection in the first trimester pregnancy uterine mucosa. PLoS One (2009) 1.08
M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. Am J Pathol (2011) 1.05
Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV. Front Immunol (2011) 0.99
Cellular and Molecular Connections between Autophagy and Inflammation. Mediators Inflamm (2015) 0.96
HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells. Scientifica (Cairo) (2013) 0.93
The macrophage: a therapeutic target in HIV-1 infection. Mol Cell Ther (2014) 0.90
Tetherin can restrict cell-free and cell-cell transmission of HIV from primary macrophages to T cells. PLoS Pathog (2014) 0.90
HIV Blocks Interferon Induction in Human Dendritic Cells and Macrophages by Dysregulation of TBK1. J Virol (2015) 0.89
Human IL10 gene repression by Rev-erbα ameliorates Mycobacterium tuberculosis clearance. J Biol Chem (2013) 0.88
Triggering TLR2, -3, -4, -5, and -8 reinforces the restrictive nature of M1- and M2-polarized macrophages to HIV. J Virol (2014) 0.88
Differential HIV-1 endocytosis and susceptibility to virus infection in human macrophages correlate with cell activation status. J Virol (2012) 0.86
Genome-wide analysis of antiviral signature genes in porcine macrophages at different activation statuses. PLoS One (2014) 0.86
Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy. Open AIDS J (2014) 0.83
Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region. J Leukoc Biol (2015) 0.83
Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination. J Virol (2014) 0.83
The role of macrophage IL-10/innate IFN interplay during virus-induced asthma. Rev Med Virol (2014) 0.82
Temporal phenotypic features distinguish polarized macrophages in vitro. Autoimmunity (2015) 0.82
Macrophage Polarization in Virus-Host Interactions. J Clin Cell Immunol (2015) 0.82
Inducible renitence limits Listeria monocytogenes escape from vacuoles in macrophages. J Immunol (2012) 0.81
FoxO1 regulates allergic asthmatic inflammation through regulating polarization of the macrophage inflammatory phenotype. Oncotarget (2016) 0.80
Protein kinase C and NF-κB-dependent CD4 downregulation in macrophages induced by T cell-derived soluble factors: consequences for HIV-1 infection. J Immunol (2011) 0.80
Antiviral regulation in porcine monocytic cells at different activation states. J Virol (2014) 0.79
Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection. Am J Pathol (2016) 0.79
The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune Cells. Biol Psychiatry (2015) 0.77
Macrophage Differentiation from Monocytes Is Influenced by the Lipid Oxidation Degree of Low Density Lipoprotein. Mediators Inflamm (2015) 0.77
Small ruminant macrophage polarization may play a pivotal role on lentiviral infection. Vet Res (2013) 0.76
Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages. Virology (2016) 0.75
Phosphodiesterase 8a supports HIV-1 replication in macrophages at the level of reverse transcription. PLoS One (2014) 0.75
Combining laboratory and mathematical models to infer mechanisms underlying kinetic changes in macrophage susceptibility to an RNA virus. BMC Syst Biol (2016) 0.75
Candida albicans delays HIV-1 replication in macrophages. PLoS One (2013) 0.75
Specific Neuropilins Expression in Alveolar Macrophages among Tissue-Specific Macrophages. PLoS One (2016) 0.75
PEDF mediates pathological neovascularization by regulating macrophage recruitment and polarization in the mouse model of oxygen-induced retinopathy. Sci Rep (2017) 0.75
Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel. Front Immunol (2017) 0.75
Roles of M1 and M2 Macrophages in Herpes Simplex Virus 1 Infectivity. J Virol (2017) 0.75
Towards an HIV cure: a global scientific strategy. Nat Rev Immunol (2012) 5.52
Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem (2008) 2.12
Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J Infect Dis (2010) 2.10
Macrophage polarization in health and disease. ScientificWorldJournal (2011) 1.46
Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol (2006) 1.42
Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathog (2013) 1.33
Macrophage polarization and HIV-1 infection. J Leukoc Biol (2009) 1.32
Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Mol Immunol (2005) 1.28
Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4). Proc Natl Acad Sci U S A (2012) 1.19
TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements. J Virol (2011) 1.16
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression. Blood (2006) 1.03
Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis. J Infect Dis (2004) 1.03
Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis. AIDS (2003) 1.03
New players in cytokine control of HIV infection. Curr HIV/AIDS Rep (2008) 1.02
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein. J Virol (2008) 1.00
M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication. AIDS (2013) 0.96
Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antivir Ther (2004) 0.94
A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity. PLoS One (2012) 0.94
Coronaviridae and SARS-associated coronavirus strain HSR1. Emerg Infect Dis (2004) 0.92
Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication. Proc Natl Acad Sci U S A (2002) 0.90
The puzzling role of CXCR4 in human immunodeficiency virus infection. Theranostics (2013) 0.90
The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection. J Leukoc Biol (2003) 0.89
HIV-1 infected lymphoid organs upregulate expression and release of the cleaved form of uPAR that modulates chemotaxis and virus expression. PLoS One (2013) 0.89
Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2. AIDS Res Hum Retroviruses (2002) 0.89
Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. Blood (2004) 0.89
Negative regulation of HIV-1 transcription by a heterodimeric NF-κB1/p50 and C-terminally truncated STAT5 complex. J Mol Biol (2011) 0.89
Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression. Blood (2007) 0.88
HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium. Blood (2009) 0.88
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT. AIDS Res Ther (2008) 0.87
Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives. AIDS (2003) 0.87
Design and characterization of a peptide mimotope of the HIV-1 gp120 bridging sheet. Int J Mol Sci (2012) 0.87
IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes. J Leukoc Biol (2002) 0.86
Preparing for phase II/III HIV vaccine trials in Africa. Microbes Infect (2005) 0.86
Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study. AIDS Res Hum Retroviruses (2010) 0.85
Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J Leukoc Biol (2007) 0.85
Retroviral interference on STAT activation in individuals coinfected with human T cell leukemia virus type 2 and HIV-1. J Immunol (2002) 0.85
Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε. PLoS One (2011) 0.84
Pertussis toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit Tat-induced TGF-beta production by NK cells and TGF-beta-mediated NK cell apoptosis. J Immunol (2005) 0.84
Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy. J Infect Dis (2013) 0.84
Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy. Haematologica (2006) 0.83
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide. Antimicrob Agents Chemother (2008) 0.83
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression. J Clin Virol (2007) 0.83
Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication. Blood (2006) 0.83
Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(+) T cells. J Leukoc Biol (2002) 0.83
Cellular localization, invasion, and turnover are differently influenced by healthy and tumor-derived extracellular matrix. Tissue Eng Part A (2014) 0.82
Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients. Int J Cancer (2003) 0.82
Macrophage polarization at the crossroad between HIV-1 infection and cancer development. Arterioscler Thromb Vasc Biol (2013) 0.82
Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells. BMC Biotechnol (2008) 0.82
NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human gamma delta lymphocytes. J Immunol (2008) 0.82
Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissue. AIDS (2005) 0.82
Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice. Int Immunol (2005) 0.81
Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection. Eur J Immunol (2003) 0.81
Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1. J Immunol (2006) 0.81
Heterogeneity of signal transducer and activator of transcription binding sites in the long-terminal repeats of distinct HIV-1 subtypes. Open Virol J (2007) 0.81
Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytes. J Transl Med (2011) 0.81
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses. J Immunol Methods (2011) 0.81
Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease. Antivir Ther (2007) 0.80
Bacterial toxins: potential weapons against HIV infection. Curr Pharm Des (2005) 0.80
Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load. Front Immunol (2013) 0.80
Infection of CD4+ primary T cells and cell lines, generation of chronically infected cell lines, and induction of HIV expression. Curr Protoc Immunol (2005) 0.80
Dendritic cells and natural killer cells in the pathogenesis of HIV infection. Immunol Res (2005) 0.79
Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells. Blood (2008) 0.79
Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease. AIDS (2013) 0.79
Accuracy and precision of dual-energy x-ray absorptiometry for ex vivo determination of mineral content in turkey poult bones. Vet Radiol Ultrasound (2003) 0.79
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. Blood (2002) 0.78
Old and new plasma biomarkers in HIV-1-infected African-American women. AIDS (2011) 0.77
CD30 ligation differentially affects CXCR4-dependent HIV-1 replication and soluble CD30 secretion in non-Hodgkin cell lines and in gamma delta T lymphocytes. Eur J Immunol (2003) 0.77
Unplugging the T cell receptor. Nat Immunol (2003) 0.77
T lymphocytes of HIV-positive individuals: preloaded guns in spite of highly active antiretroviral therapy? AIDS (2004) 0.77
Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration. AIDS (2003) 0.76
HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines. Blood (2012) 0.76
Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer. Eur J Immunol (2004) 0.76